Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s share price was down 3.6% during trading on Tuesday . The company traded as low as $1.90 and last traded at $1.90. Approximately 38,020 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 1,388,685 shares. The stock had previously closed at $1.97.
Hillstream BioPharma Stock Performance
The company’s 50 day simple moving average is $2.05 and its 200-day simple moving average is $2.29. The firm has a market capitalization of $33.45 million, a PE ratio of -2.64 and a beta of 3.08.
About Hillstream BioPharma
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
See Also
- Five stocks we like better than Hillstream BioPharma
- When to Sell a Stock for Profit or Loss
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What Are Dividend Achievers? An Introduction
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Best Stocks Under $5.00
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
